CHINA JOINT VENTURE

9 Months Ended

Sep. 30, 2022

In 2019, the Company executed a joint venture agreement with its Chinese supplier (the “China JV”) whereby the Company has a 51% interest. The China JV has been consolidated in these condensed consolidated financial statements. The agreement required the Company to make capital contributions into the newly formed entity of approximately $357,000, which had been fully funded as of December 31, 2021. As of the date of these condensed consolidated financial statements, the China JV has not commenced principal operations.

Changes in the Company’s investment in the China JV were as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2022		2021		2022		2021
Beginning interest in China JV	$	269	$	338	$	317	$	144
Contributions	$	—	$	—	$	—	$	203
Net loss attributable to Apyx	$	(33)	$	(13)	$	(81)	$	(22)
Ending interest in China JV	$	236	$	325	$	236	$	325